Skip to main content
Parker Cancer ends here

Partners

Better, Together

The old wisdom: go fast alone; go far together. Our way? Go far and fast, together. Our relationships make it possible. Through relentless collaboration, we’re making sure life-saving science reaches the patients who need it, sooner.

Group of scientists in a lab
Antoni Ribas, MD, PhD
Carl H. June, MD
Julia Carnevale, MD
Ansuman T. Satpathy, MD, PhD
Alexander Marson, MD, PhD
Catherine J. Wu, MD photo

Our Research Partners

Thirteen leading cancer centers, one shared mission. Our member institutions and satellite centers bring together immuno-oncology’s top investigators. The end of cancer starts in these labs.

Visit our directory

Investment Partners

Groundbreaking science requires smart capital. Because we are uniquely positioned to de-risk the breakthroughs discovered at our institutes, we can bring medicines closer to patients through our innovation partners and portfolio companies. We are grateful our co-investors, syndicate and venture partners share our belief that big bets are the best way to end cancer.